Johnson & Johnson To Buy Actelion For $30bn

Swiss company’s research and development unit to be spun out prior to takeover

BING NEWS:
  • Johnson & Johnson set to buy Intra-Cellular for $14.6B
    Johnson & Johnson is starting the year off strong with a $14.6 billion acquisition of the biopharma firm Intra-Cellular Therapies — best known for its blockbuster drug Caplyta. The deal was announced ...
    01/13/2025 - 4:56 am | View Link
  • Johnson & Johnson Buys Intra-Cellular Therapeutics In A Whopping $14.6 Billion Deal
    Johnson & Johnson kicked off the J.P. Morgan Healthcare Conference on Monday with the $14.6 billion acquisition of Intra-Cellular Therapies.
    01/13/2025 - 4:12 am | View Link
  • Cravath, Davis Polk Steer J&J's $14.6 Billion Intra-Cellular Buy
    Cravath, Swaine & Moore guided Johnson & Johnson in its $14.6 billion plan to purchase Intra-Cellular Therapies Inc., a company focused on treatments for central nervous systems. Davis Polk & Wardwell ...
    01/13/2025 - 2:41 am | View Link
  • Strategic Acquisition and Strong Growth Prospects Drive Buy Rating for Johnson & Johnson
    TD Cowen analyst Joseph Thome has maintained their bullish stance on ITCI stock, giving a Buy rating today.Stay Ahead of the Market:Discover ...
    01/13/2025 - 12:55 am | View Link
  • Johnson & Johnson in $14.6 Billion Deal to Buy Biotech Intra-Cellular
    Johnson & Johnson has entered an agreement to acquire all outstanding shares of Intra-Cellular Therapies, in a multibillion-dollar bet on mental health therapies. Johnson & Johnson will pay $132 per ...
    01/13/2025 - 12:39 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News